SCHEMBL32665063

SCHEMBL32665063

O=C1C=CC(=O)N1c1cccc(S(=O)(=O)F)c1

nearest known ligand 0.62

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MGLL Q99685 13/20 0.62
FAAH O00519 6/20 0.62
HSP90AA1 P07900 3/20 0.53
ALDH1A1 P00352 2/20 0.51
PKM P14618 2/20 0.51
HTT P42858 2/20 0.51
ATM Q13315 1/20 0.51
HPN P05981 1/20 0.47
CA1 P00915 2/20 0.43
CA2 P00918 2/20 0.43
CA7 P43166 2/20 0.43
CA12 O43570 1/20 0.42
CA9 Q16790 1/20 0.42
MAPT P10636 1/20 0.38
HPGD P15428 1/20 0.38
XBP1 P17861 1/20 0.38
MAPK1 P28482 1/20 0.38
CCR6 P51684 1/20 0.38
SMN1; SMN2 Q16637 1/20 0.38
NPSR1 Q6W5P4 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30408507 0.85 MGLL (0.67) MGLLFAAHHSP90AA1ALDH1A1PKM
SCHEMBL2124055 0.85 MGLL (0.67) MGLLFAAHHSP90AA1ALDH1A1PKM
SCHEMBL9718444 0.85 MGLL (0.67) MGLLFAAHHSP90AA1ALDH1A1PKM
SCHEMBL29510588 0.82 CA1 (0.62) MGLLFAAHHSP90AA1ALDH1A1PKM
SCHEMBL28752515 0.82 CA1 (0.62) MGLLFAAHHSP90AA1ALDH1A1PKM
SCHEMBL94730 0.78 MGLL (1.00) MGLLFAAHHSP90AA1ALDH1A1PKM
SCHEMBL1838889 0.78 MGLL (1.00) MGLLFAAHHSP90AA1ALDH1A1PKM
SCHEMBL32665177 0.77 MGLL (0.62) MGLLFAAHHSP90AA1ALDH1A1PKM
SCHEMBL30958998 0.76 MGLL (0.95) MGLLFAAHHSP90AA1ALDH1A1PKM
SCHEMBL32665044 0.76 MGLL (0.60) MGLLFAAHHSP90AA1ALDH1A1PKM

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20260021192-A1 PROTEINS HAVING A COVALENT WARHEAD TOPAZ THERAPEUTICS INC (US) 2026-01-22 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20260021192-A1 PROTEINS HAVING A COVALENT WARHEAD RIOX2, ORC3, DCLRE1A MGLL 4200/4885FAAH 4428/4885HSP90AA1 1275/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.